Gala Health
#14A low headline rate that is only available on a yearly subscription, reaching all 50 states with a brand-name Ozempic path and HRT care under the same roof.
- Sema
- Not disclosed
- Tirz
- $179/mo (yearly subscription)
- Coverage
- All 50 states
Ranked by the Match Score
Form Health scores 56 on our six-factor Match Score (ranked #404 of 537). Here are the providers we'd weigh against it, ranked by that same honest model. Or take the quiz for your personalized match.
A low headline rate that is only available on a yearly subscription, reaching all 50 states with a brand-name Ozempic path and HRT care under the same roof.
The best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.
Amazon One Medical is the unified Amazon GLP-1 channel — One Medical clinicians prescribe FDA-approved Wegovy, Zepbound, and Foundayo (no compounded products), and Amazon Pharmacy fulfills with same-day…
A performance-and-longevity clinic that also prescribes a compounded GLP-1/GIP, priced openly at $179/mo once the first-month promo lapses.
Levity is a telehealth weight loss provider dispensing FDA-approved branded GLP-1 medications only, with no compounded options.
Regulatory notice
FDA issued Levity Inc. dba Levity a warning letter in February 2026. You can read it in FDA's warning-letter database. We still list Levity, and we may earn a commission if you start care through the link on this page.
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform.
Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss.
Answer six quick questions and we'll reweight the Match Score to your budget, format, timing, coverage and support — then rank every provider for you.
Take the quizPricing, states and verification reflect each provider's public disclosures at last review; the Match Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.